Skip to the main content
The Crier

GB-Salisbury: Pharma in vitro metabolism

C Redwoodservices
Your saved contracts

What the buyer wrote

In vitro metabolism of the API being developed by Dstl and how this will be used to improve the understanding of the drugs as the project moves forwards to clinical trials. API must be completed to Good Laboratory Practice (GLP). Only Suppliers that have the mandatory GLP systems in place should express interest in this requirement. Additional information: To view this notice, register as a supplier here: http://www.contracts.mod.uk/delta/signup.html?userType=supplier and search for the notice with reference 'GB-Salisbury: Pharma in vitro metabolism'.

Bid for this and lost? There is a short window in which the decision can be questioned.

Awarded to

BioFocus DPI Limited£136.3kends (30 Jun 2017)

Details

What the buyer calls it
GB-Salisbury: Pharma in vitro metabolism
How they are buying
Advertised, open to anyoneAny supplier could bid without being invited first.
Type
services
Work starts
3 Nov 2016
Work ends
30 Jun 2017

Who the buyer named

C Redwood was the named contact on this notice.

credwood@dstl.gov.uk